Logo image of TPST

TEMPEST THERAPEUTICS INC (TPST) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:TPST - US87978U2078 - Common Stock

2.81 USD
+0.02 (+0.72%)
Last: 1/29/2026, 8:00:02 PM
2.7737 USD
-0.04 (-1.29%)
After Hours: 1/29/2026, 8:00:02 PM
Fundamental Rating

2

Overall TPST gets a fundamental rating of 2 out of 10. We evaluated TPST against 525 industry peers in the Biotechnology industry. The financial health of TPST is average, but there are quite some concerns on its profitability. TPST does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

  • TPST had negative earnings in the past year.
  • In the past year TPST has reported a negative cash flow from operations.
  • In the past 5 years TPST always reported negative net income.
  • In the past 5 years TPST always reported negative operating cash flow.
TPST Yearly Net Income VS EBIT VS OCF VS FCFTPST Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 -20M -40M -60M -80M

1.2 Ratios

  • With a Return On Assets value of -210.49%, TPST is not doing good in the industry: 88.19% of the companies in the same industry are doing better.
  • TPST's Return On Equity of -568.14% is on the low side compared to the rest of the industry. TPST is outperformed by 75.81% of its industry peers.
Industry RankSector Rank
ROA -210.49%
ROE -568.14%
ROIC N/A
ROA(3y)-78.49%
ROA(5y)-71.6%
ROE(3y)-175.41%
ROE(5y)-142.93%
ROIC(3y)N/A
ROIC(5y)N/A
TPST Yearly ROA, ROE, ROICTPST Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 -50 -100 -150 -200

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for TPST so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
TPST Yearly Profit, Operating, Gross MarginsTPST Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 -5K -10K -15K

5

2. Health

2.1 Basic Checks

  • TPST has more shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, TPST has more shares outstanding
  • Compared to 1 year ago, TPST has an improved debt to assets ratio.
TPST Yearly Shares OutstandingTPST Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M
TPST Yearly Total Debt VS Total AssetsTPST Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

  • Based on the Altman-Z score of -24.67, we must say that TPST is in the distress zone and has some risk of bankruptcy.
  • TPST's Altman-Z score of -24.67 is on the low side compared to the rest of the industry. TPST is outperformed by 84.76% of its industry peers.
  • There is no outstanding debt for TPST. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -24.67
ROIC/WACCN/A
WACCN/A
TPST Yearly LT Debt VS Equity VS FCFTPST Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M

2.3 Liquidity

  • A Current Ratio of 2.30 indicates that TPST has no problem at all paying its short term obligations.
  • TPST has a Current ratio of 2.30. This is in the lower half of the industry: TPST underperforms 72.57% of its industry peers.
  • TPST has a Quick Ratio of 2.30. This indicates that TPST is financially healthy and has no problem in meeting its short term obligations.
  • TPST has a Quick ratio of 2.30. This is in the lower half of the industry: TPST underperforms 70.10% of its industry peers.
Industry RankSector Rank
Current Ratio 2.3
Quick Ratio 2.3
TPST Yearly Current Assets VS Current LiabilitesTPST Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

1

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 50.76% over the past year.
EPS 1Y (TTM)50.76%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%85.18%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • TPST is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 11.92% yearly.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y33.15%
EPS Next 2Y7.8%
EPS Next 3Y9.22%
EPS Next 5Y11.92%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
TPST Yearly Revenue VS EstimatesTPST Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2028 2030 2031 2032 50M 100M 150M 200M
TPST Yearly EPS VS EstimatesTPST Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 -2K -4K -6K

0

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for TPST. In the last year negative earnings were reported.
  • Also next year TPST is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
TPST Price Earnings VS Forward Price EarningsTPST Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
TPST Per share dataTPST EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -5 -10 -15

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y7.8%
EPS Next 3Y9.22%

0

5. Dividend

5.1 Amount

  • No dividends for TPST!.
Industry RankSector Rank
Dividend Yield 0%

TEMPEST THERAPEUTICS INC / TPST FAQ

What is the fundamental rating for TPST stock?

ChartMill assigns a fundamental rating of 2 / 10 to TPST.


What is the valuation status of TEMPEST THERAPEUTICS INC (TPST) stock?

ChartMill assigns a valuation rating of 0 / 10 to TEMPEST THERAPEUTICS INC (TPST). This can be considered as Overvalued.


Can you provide the profitability details for TEMPEST THERAPEUTICS INC?

TEMPEST THERAPEUTICS INC (TPST) has a profitability rating of 0 / 10.


How financially healthy is TEMPEST THERAPEUTICS INC?

The financial health rating of TEMPEST THERAPEUTICS INC (TPST) is 5 / 10.


What is the expected EPS growth for TEMPEST THERAPEUTICS INC (TPST) stock?

The Earnings per Share (EPS) of TEMPEST THERAPEUTICS INC (TPST) is expected to grow by 33.15% in the next year.